ATE204163T1 - Verkapselter arzneistoff - Google Patents

Verkapselter arzneistoff

Info

Publication number
ATE204163T1
ATE204163T1 AT94918588T AT94918588T ATE204163T1 AT E204163 T1 ATE204163 T1 AT E204163T1 AT 94918588 T AT94918588 T AT 94918588T AT 94918588 T AT94918588 T AT 94918588T AT E204163 T1 ATE204163 T1 AT E204163T1
Authority
AT
Austria
Prior art keywords
pct
date jan
sec
insoluble compound
practically insoluble
Prior art date
Application number
AT94918588T
Other languages
English (en)
Inventor
Takehisa Hata
Fumio Shimojo
Kazutake Kado
Kyoko Ishii
Seiji Sawai
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Application granted granted Critical
Publication of ATE204163T1 publication Critical patent/ATE204163T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT94918588T 1993-06-30 1994-06-28 Verkapselter arzneistoff ATE204163T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP16098393 1993-06-30
PCT/JP1994/001043 WO1995001166A1 (en) 1993-06-30 1994-06-28 Encapsulated medicine

Publications (1)

Publication Number Publication Date
ATE204163T1 true ATE204163T1 (de) 2001-09-15

Family

ID=15726345

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94918588T ATE204163T1 (de) 1993-06-30 1994-06-28 Verkapselter arzneistoff

Country Status (15)

Country Link
US (1) US5683716A (de)
EP (1) EP0706380B1 (de)
JP (1) JPH09501150A (de)
KR (1) KR960703335A (de)
CN (1) CN1087933C (de)
AT (1) ATE204163T1 (de)
AU (1) AU682192B2 (de)
CA (1) CA2165789A1 (de)
DE (1) DE69427981T2 (de)
DK (1) DK0706380T3 (de)
ES (1) ES2161768T3 (de)
GR (1) GR3036407T3 (de)
PT (1) PT706380E (de)
TW (1) TW360543B (de)
WO (1) WO1995001166A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5919481A (en) * 1996-06-28 1999-07-06 Ncneil-Ppc, Inc. Fill material for soft gelatin pharmaceutical dosage form
US6024980A (en) * 1996-06-28 2000-02-15 Mcneil-Ppc, Inc. Multiphase soft gelatin dosage form
US6555139B2 (en) 1999-06-28 2003-04-29 Wockhardt Europe Limited Preparation of micron-size pharmaceutical particles by microfluidization
AU2001232344A1 (en) * 2000-02-21 2001-08-27 Fujisawa Pharmaceutical Co. Ltd. Liquid preparation with improved absorbability
US6635277B2 (en) 2000-04-12 2003-10-21 Wockhardt Limited Composition for pulsatile delivery of diltiazem and process of manufacture
WO2002094173A2 (en) * 2001-05-22 2002-11-28 Euro-Celtique Tamper resistant oral dosage form
US20030077378A1 (en) * 2001-10-22 2003-04-24 Lou Wen Chin Hydroxypropyl cellulose encapsulation material
CN101883564B (zh) * 2007-10-05 2013-10-16 阿尔茨海默病学会美国公司 使用(-)-尼伐地平对映体减少淀粉状蛋白沉积、淀粉状蛋白神经毒性和小神经胶质增生的方法
JP5750278B2 (ja) * 2011-02-28 2015-07-15 東洋カプセル株式会社 カンデサルタンシレキセチルのカプセル充填用組成物
WO2014010008A1 (ja) * 2012-07-09 2014-01-16 東洋カプセル株式会社 カンデサルタンシレキセチルのカプセル充填用組成物
WO2014074555A1 (en) 2012-11-06 2014-05-15 CoLabs International Corporation Composition containing a cellulose derived capsule with a sunscreen
US10322301B2 (en) 2012-11-06 2019-06-18 CoLabs International Corporation Compositions containing a cellulose derived capsule with a sunscreen active agent
US11690793B2 (en) 2012-11-06 2023-07-04 Colabs Int'l Corp. Composition containing a cellulose derived capsule with a sunscreen
US11491088B2 (en) 2012-11-06 2022-11-08 CoLabs International Corporation Compositions containing a capsule with a moisturizing agent
US11724134B2 (en) 2012-11-06 2023-08-15 CoLabs International Corporation Compositions containing a cellulose derived capsule with a sunscreen active agent
US11707421B2 (en) 2012-11-06 2023-07-25 Colabs Int'l Corp. Compositions containing a flexible derived capsule with an active agent
EP3813786A4 (de) 2018-06-27 2022-06-29 Colabs International Corporation Zusammensetzungen mit siliziumdioxidbasierten partikeln, die ein oder mehrere mittel enthalten

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8507779D0 (en) * 1985-03-26 1985-05-01 Fujisawa Pharmaceutical Co Drug carrier
DE3636123A1 (de) * 1986-10-23 1988-05-05 Rentschler Arzneimittel Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten
GB8629761D0 (en) * 1986-12-12 1987-01-21 Harris Pharma Ltd Capsules
KR920008948B1 (ko) * 1987-02-12 1992-10-12 니혼 덴네쯔 게이기 가부시끼가이샤 프린트 기판의 납땜방법 및 그의 장치
US5340591A (en) * 1992-01-24 1994-08-23 Fujisawa Pharmaceutical Co., Ltd. Method of producing a solid dispersion of the sparingly water-soluble drug, nilvadipine

Also Published As

Publication number Publication date
AU6984294A (en) 1995-01-24
DK0706380T3 (da) 2001-10-08
AU682192B2 (en) 1997-09-25
US5683716A (en) 1997-11-04
JPH09501150A (ja) 1997-02-04
CA2165789A1 (en) 1995-01-12
CN1087933C (zh) 2002-07-24
ES2161768T3 (es) 2001-12-16
CN1127990A (zh) 1996-07-31
TW360543B (en) 1999-06-11
EP0706380B1 (de) 2001-08-16
WO1995001166A1 (en) 1995-01-12
PT706380E (pt) 2002-02-28
DE69427981T2 (de) 2001-11-29
DE69427981D1 (de) 2001-09-20
GR3036407T3 (en) 2001-11-30
EP0706380A1 (de) 1996-04-17
KR960703335A (ko) 1996-08-17

Similar Documents

Publication Publication Date Title
DE69427981D1 (de) Verkapselter arzneistoff
ATE211907T1 (de) Osmotisches arzneimittelfreisetzungssystem
RU94032150A (ru) Лекарственное средство с замедленным высвобождением активно-действующего вещества
DE59609926D1 (de) Stabilisierte schilddrüsenhormonhaltige arzneimittel
UA85664C2 (ru) Фармацевтическая лекарственная форма десмопрессина ацетата, способ ее получения, применение и упаковка
KR960700059A (ko) 파킨슨씨 병 및 파킨슨 중후군의 치료에 카르바마제핀 및 옥스카르바제핀의 이용(application of carbamazepine and oxcarbazepine in the treatment of parkinson's disease and parkinsonian syndromes)
NO163356C (no) Fremgangsmaate for fremstilling av en farmasoeytisk tablettsom gir hovedsakelig nullte ordens frigivelse av medikament.
ES2040232T3 (es) Preparaciones medicinales para administracion oral conteniendo una sola dosis de 10 a 240 mg de dihidropiridina.
ATE213633T1 (de) Lamotrigin haltiges arzneimittel
IT1240768B (it) Composizione farmaceutica contenente ranitidina sotto forma di capsule di gelatina.
DE69504509D1 (de) Thiazolidinderivate, ihre herstellung und medikamente, die sie enthalten
KR960000217A (ko) L- 카르니틴염과 이를 함유한 조성물
HUP9801414A2 (hu) Nátrium-alginátot és kálium-bikarbonátot tartalmazó folyékony vizes gyógyszerkészítmények
TR200101163T2 (tr) Safra suyu ikameli fenil-alkenoilguanidinler, üretim yöntemleri, kullanımları
ATE280578T1 (de) Kombination von einem den retinoinsäure metabolismus blockierenden arzneimittel und einem tocopherol
AU7775398A (en) Novel glycosylated ginkgolide derivatives, their application as medicines and pharmaceutical compositions
DE59503283D1 (de) Carbamazepin-arzneiform mit verzögerter wirkstofffreisetzung
FI951961A0 (fi) Tilidiinidivetyortofosfatti, menetelmä sen valmistamiseksi ja sitä sisältäviä farmaseuttisia valmisteita
DE69616591D1 (de) Pharmazeutische zusammensetzung, die muirapuama und pflanzenwürmer enthaelt
ES2137665T3 (es) Nuevos derivados de piridina o piridazina, procedimientos para su preparacion, y medicamentos que contienen estos compuestos.
FR2673105B1 (fr) Nouvelles compositions pharmaceutiques, notamment pour le traitement des colopathies fonctionnelles, et procedes de preparation de compositions et de medicaments, notamment pour le traitement de ces affections.
KR950700063A (ko) 외상후 스트레스 치료제로서의 브로파로민(Brofaromine as an agent for treating post-traumatic stress)
KR910004181A (ko) 생체내 유효성을 증가시키는 신규의 제약학적 경구 투여 형태
KR970005291A (ko) 단백다당체 g009를 함유하는 간질환 치료제 조성물
RU95115409A (ru) Применение противосудорожных средств при лечении болезни паркинсона и синдромов паркинсона

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee